After attaining a 1st class degree in Theology from Durham University, Jessica returned to Kent to join the graduate programme here at CREATION.co. She uses her research and analytical skills to inform health strategy and serve clients.
Outside of work, Jessica loves to travel and visit historical landmarks. She also enjoys mini-golf and going out for brunch with friends and family.
15.12.2025 | Article
Between September and November 2025, we analysed 6,500 HCP mentions.
By Jessica Fernandes
15.10.2025 | Article
We use DOL Finder in Heart failure to explore another HCP profile. Meet Martha Gulati, MD.
By Jessica Fernandes
22.09.2025 | Article
HCPs celebrated approvals but expressed concerns about access, cost and toxicities.
By Jessica Fernandes
26.08.2025 | Article
HCPs discussed many topics in over 7,600 social media posts relating the ESC congress.
By Bernard Groen and Jessica Fernandes
05.08.2025 | Article
10,000 social media posts from more than 3,000 verified HCPs worldwide discussing Bristol My
By Jessica Fernandes
14.07.2025 | Article
Evidence-based insights on Novartis' digital influence.
By Bernard Groen and Jessica Fernandes
11.06.2025 | Article
From March-May 2025, CREATION.co analysed mentions of launches, approvals and new products.
By Jessica Fernandes
24.03.2025 | Article
Meet Beverly Tchang, MD, who ranks among the top 10 HCPs worldwide discussing obesity.
By Jessica Fernandes
17.03.2025 | Article
CREATION.co identified 8,501 HCP mentions on social media of launches and approvals.
By Jessica Fernandes
26.02.2025 | Article
We track the conversation around the latest approvals and data releases of new ADCs.
By Jessica Fernandes
31.01.2025 | Article
We tracked the online conversation of HCPs on social media.
By Jessica Fernandes
22.11.2024 | Article
Discover which drug approvals HCPs are talking about online.
By Jessica Fernandes
15.11.2024 | Article
How social media intelligence can support the launch of blockbusters like GSK’s depemokimab.
By Jessica Fernandes
22.10.2024 | Article
An overview of the HCP conversation online around momelotinib in myelofibrosis.
By Jessica Fernandes
18.10.2024 | Article
Discover which drug approvals HCPs are talking about online.
By Jessica Fernandes
10.10.2024 | Article
Analysis of the HCP conversation at ESMO 2024.
By Jessica Fernandes
03.10.2024 | Article
A look at the social media impact of top 10 pharma CEOs in 2024.
By Jessica Fernandes
11.09.2024 | Article
Discover which drug approvals HCPs are talking about online.
By Jessica Fernandes